¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"single cell protein"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • duct cell carcinoma
    °ü¼¼Æ÷¾ÏÁ¾
  • dust cell
    ¸ÕÁö¼¼Æ÷
  • delayed cell-mediated reaction
    Áö¿¬¼¼Æ÷¸Å°³¹ÝÀÀ
  • delta cell
    µ¨Å¸¼¼Æ÷
  • dendritic cell
    °¡Áö¼¼Æ÷, ¼öÁö»ó¼¼Æ÷
  • dark cell
    ¾îµÒ¼¼Æ÷
  • daughter cell
    µþ¼¼Æ÷
  • differentiated cell
    ºÐÈ­¼¼Æ÷
  • diffuse large B-cell lymphoma
    ±¤¹üÀ§Å«B¼¼Æ÷¸²ÇÁÁ¾
  • diploid cell
    µÎ¹è¼öü¼¼Æ÷
  • diploid cell line
    µÎ¹è¼öü¼¼Æ÷°è, À̹èü¼¼Æ÷°è
  • diploid cell strain
    µÎ¹è¼öü¼¼Æ÷ÁÖ
  • decoy cell
    µðÄÚÀ̼¼Æ÷
  • effector cell
    ÀÛµ¿¼¼Æ÷
  • egg cell
    ³­¼¼Æ÷, ¾Ë¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • dendritic cell
    °¡Áö¼¼Æ÷
  • differentiated cell
    ºÐÈ­¼¼Æ÷
  • diploid cell
    µÎ¹è¼öü¼¼Æ÷
  • duct cell carcinoma
    °ü¼¼Æ÷¾ÏÁ¾
  • dust cell
    ¸ÕÁö¼¼Æ÷
  • effector cell
    ÀÛµ¿¼¼Æ÷
  • egg cell
    ³­¼¼Æ÷, ¾Ë¼¼Æ÷
  • endothelial cell
    ³»ÇǼ¼Æ÷
  • enterochromaffine cell
    âÀÚģũ·Ò¼¼Æ÷, âÀÚÅ©·Òģȭ¼¼Æ÷
  • eosinophilic cell
    È£»ê¼¼Æ÷
  • ependymal cell
    ³ú½Ç¸·¼¼Æ÷
  • epidermal cell
    Ç¥ÇǼ¼Æ÷
  • epithelial cell
    »óÇǼ¼Æ÷
  • epithelioid cell
    »óÇǸð¾ç¼¼Æ÷
  • erythroid cell
    (¢¡red blood cell) ÀûÇ÷±¸
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • apex of cell
    ¼¼Æ÷²À´ë±â
  • apical cell
    Á¤(´Ü)¼¼Æ÷(ð¢Ó®á¬øà)
  • argentaffin chromaffin cell
    Å©·Òģȭ¼º ¼¼Æ÷
  • argyrophil(e) cell
    ÀºÄ£È­¼º ¼¼Æ÷(ëÞöÑûúàõá¬øà)
  • arsenical basal cell carcinoma
    ºñ¼Ò¼º(Ý÷áÈàõ) ±âÀú¼¼Æ÷¾Ï
  • arteritis,giant cell of aorta
    ´ëµ¿¸Æ(ÓÞÔÑØæ)ÀÇ °Å¼¼Æ÷¼º(ËÝá¬øààõ)
  • free cell
    ÀÚÀ¯¼¼Æ÷(í»ë¦á¬øà).
  • functional cell
    ±â´É¼¼Æ÷(ѦÒöá¬øà).
  • funicular cell
    ÁÙ¼¼Æ÷, »è¼¼Æ÷(ßãá¬øà).
  • fusiform cell
    ¹æÃß¼¼Æ÷
  • fusiform endothelial cell
    ¹æÃß³»ÇǼ¼Æ÷
  • fusiform myoepithelial cell
    ¹æÃßÇü ±Ù»óÇÇ ¼¼Æ÷
  • fusiform myoepithelial cell
    ¹æÃß±ÙÀ°»óÇǼ¼Æ÷
  • fusion, cell
    ¼¼Æ÷À¶ÇÕ
  • gangliocyte =ganglion cell
    ½Å°æÀý¼¼Æ÷(¡­á¬øà).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • protein separation
    ´Ü¹éºÐ¸®
  • protein sparing effect
    ´Ü¹éÁúÀý¾àÈ¿°ú(Ó±ÛÜòõï½å³üùÍý).
  • protein synthesis
    ´Ü¹éÁúÇÕ¼º.
  • protein synthesis factor
    ´Ü¹éÇÕ¼ºÀÎÀÚ(Ó±ÛÜùêà÷ì×í­).
  • protein therapy
    ´Ü¹é(Áú)¿ä¹ý(¡­èþÛö).
  • protein,actin-binding
    ¾×ƾ-°áÇÕ(´Ü¹é)
  • protein,al
    AL(´Ü¹é)
  • protein,bence jones
    º¥½º-Á¸½º(´Ü¹é)
  • protein-calorie deficiency
    ´Ü¹é(Áú)¿­·®°áÇÌ(Ó±ÛÜ(òõ)æðÕáÌÀù¹)
  • protein-calorie malnutrition
    ´Ü¹é(Áú)¿­·®¿µ¾ç½ÇÁ¶(Áõ)(Ó±ÛÜ(òõ)æðÕáç½å×ã÷ðà(ñø))
  • protein-energy malnutrition
    ´Ü¹é(Áú)¿¡³ÊÁö¿µ¾ç½ÇÁ¶(Áõ)(¡­ç½å×ã÷ðà(ñø))
  • protein-losing
    ´Ü¹é»ó½Ç¼º.
  • protein-losing enteropathy
    ´Ü¹é»ó½Ç¼º À庴Áõ(íóÜ»ñø)
  • protein-losing enteropathy
    ´Ü¹é»ó½ÇÀ庴Áõ(Ó±ÛÜßÃã÷íóÜ»ñø)
  • purified protein derivative
    Á¤Á¦´Ü¹éÁúÀ¯µµÃ¼.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • Lutein cell
    Ȳ(»ö)ü¼¼Æ÷
    [¿¾ ¿ë¾î] Ȳü¼¼Æ÷
  • Sensory cell
    °¨°¢¼¼Æ÷
    [¿¾ ¿ë¾î] °¨°¢¼¼Æ÷
  • Rod cell
    ¸·´ë¼¼Æ÷
    [¿¾ ¿ë¾î] °£»óü½Ã¼¼Æ÷
  • Mucous neck cell
    ¸ñÁ¡¾×¼¼Æ÷
    [¿¾ ¿ë¾î] Á¡¸·°æ¼¼Æ÷
  • Smooth muscle cell
    ¹Î¹«´Ì±ÙÀ°¼¼Æ÷
    [¿¾ ¿ë¾î] ÆòȰ±Ù¼¼Æ÷
  • Hensen`s cell
    ¹Ù±ù°æ°è¼¼Æ÷
    [¿¾ ¿ë¾î] ¿Ü°æ°è¼¼Æ÷
  • M ller cell
    ºÎê»ì¾Æ±³¼¼Æ÷
    [¿¾ ¿ë¾î] ¹æ»ç±³¼¼Æ÷
  • Pole of cell
    ¼¼Æ÷±Ø
    [¿¾ ¿ë¾î] ¼¼Æ÷±Ø
  • Cell cycle
    ¼¼Æ÷ÁÖ±â
    [¿¾ ¿ë¾î] ¼¼Æ÷ÁÖ±â
  • Border cell
    ¼Ó°æ°è¼¼Æ÷
    [¿¾ ¿ë¾î] ³»°æ°è¼¼Æ÷
  • Goblet cell
    ¼úÀܼ¼Æ÷
    [¿¾ ¿ë¾î] ¹è»ó[Á¡¾×]¼¼Æ÷
  • Neurosensory cell
    ½Å°æ°¨°¢¼¼Æ÷
    [¿¾ ¿ë¾î] ½Å°æ°¨°¢¼¼Æ÷
  • Neurosensory cell body
    ½Å°æ°¨°¢¼¼Æ÷ü
    [¿¾ ¿ë¾î] ½Å°æ°¨°¢¼¼Æ÷ü
  • Nerve cell [Neuron]
    ½Å°æ¼¼Æ÷ [½Å°æ´ÜÀ§]
    [¿¾ ¿ë¾î] ½Å°æ¼¼Æ÷
  • Nerve cell body
    ½Å°æ¼¼Æ÷ü
    [¿¾ ¿ë¾î] ½Å°æ¼¼Æ÷ü
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • helix-destabilizing protein
    ³ª¼± ºÒ¾ÈÁ¤È­ ´Ü¹éÁú(Õ¢àÁÝÕäÌïÒûùÓ±ÛÜòõ)
  • heme protein
    Èû´Ü¹éÁú(Ó±ÛÜòõ)
  • high-potential iron protein
    °íÀüÀ§(ÍÔï³êÈ) ö´Ü¹éÁú(ôÑÓ±ÛÜòõ)
  • homologous protein
    µ¿Á¾´Ü¹éÁú(ÔÒðúÓ±ÛÜòõ)
  • hybrid protein
    Æ¢±â´Ü¹éÁú(Ó±ÛÜòõ)
  • hypro-protein
    ÇÏÀÌÇÁ·Î´Ü¹éÁú(Ó±ÛÜòõ)
  • incomplete protein
    ºÒ¿ÏÀü ´Ü¹éÁú(ÝÕèÇîïÓ±ÛÜòõ)
  • inside-out protein
    ³»¿ÜÀüµµ ´Ü¹éÁú(Ò®èâï´ÓîÓ±ÛÜòõ)
  • internal protein
    ³»´Ü¹éÁú(Ò®Ó±ÛÜòõ)
  • intrinsic protein
    °íÀ¯ ´Ü¹éÁú(ͳêóÓ±ÛÜòõ)
  • in vitro protein synthesis
    ½ÃÇè°ü³» ´Ü¹éÁúÇÕ¼º(ãËúÐηҮ Ó±ÛÜòõùêà÷)
  • I protein
    I ´Ü¹éÁú(Ó±ÛÜòõ)
  • I region-associated protein
    I ºÎÀ§¿¬°ü(Ý»êÈ֤μ) ´Ü¹éÁú(Ó±ÛÜòõ)
  • iron protein
    ö´Ü¹éÁú(ôÑÓ±ÛÜòõ)
  • iron-sulfur protein
    ö-À¯È² ´Ü¹éÁú(ôÑ×¼üÜÓ±ÛÜòõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
SCU-PA single-chain urokinase plasminogen activator
SDS same day surgery; school dental services; self-rating depression scale; sensory deprivation syndrome...
SDSL symmetrical digital single line
SDT sensory detection theory; right sacrotransverse [fetal position] [Lat. sacrodextra transversa]; sign...
sEP single evoked potential
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
scu-PA Single-chain u-PA
scu-PA Single-chain urokinase-type plasminogen activator
Sim Single-minded
SN Single-nephron
SNPF Single-nephron plasma flow
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • eosinophilic cell
    È£»ê±¸
  • epidermoid type cell
    À¯Ç¥ÇÇ ¼¼Æ÷
  • epithelioid cell
    »óÇÇ¾ç ¼¼Æ÷, À¯»óÇÇ ¼¼Æ÷
    °áÇÙ µîÀÇ À°¾Æ¼º ¿°Áõ Áúȯ¿¡ À־ À°¾Æ ¼Ó¿¡¼­ È®ÀÎÇÒ ¼ö ÀÖ´Â Á¶Á÷±¸ÀÇ È£Äª.
  • ethmoid cell
    »ç°ñ ¹úÁý, »ç°ñ ºÀ¼Ò
  • eukaryotic cell
    ÁøÇÙ ¼¼Æ÷
  • excretory cell
    ¹è¼³ ¼¼Æ÷
  • fat cell
    Áö¹æ ¼¼Æ÷
  • fetal liver cell
    ÅÂ¾Æ °£ ¼¼Æ÷
    ÅÂ¾Æ °£ ¼¼Æ÷, Á¶Ç÷ stem ¼¼Æ÷°¡ µé¾î ÀÖ°í, µû¶ó¼­ °¢Á¾ ¸é¿ª ¼¼Æ÷ÀÇ Àü±¸ ¼¼Æ÷¸¦ Æ÷ÇÔÇÑ´Ù. ÃÖ±Ù ¸é¿ªºÎÀüÀÇ Áúȯ, ¿¹¸¦ µé¸é ÁßÁñ º¹ÇÕ ¸é¿ª ºÎÀüÁõ¿¡¼­´Â Á¶Á÷ ÀûÇÕ °ñ¼ö¸¦ ¾òÁö ¸øÇÏ´Â °æ¿ì, 8ÁÖ ÀÌÀüÀÇ ÅÂ¾Æ °£¼¼Æ÷ÀÇ À̽ÄÀÌ ÀÌ·ç¾îÁ® Àå±â°£ÀÇ »ýÁ¸ ¿¹¸¦ º¼ ¼ö ÀÖ´Ù.
  • fibroma-theca cell tumor
    ¼¶À¯Á¾-³­Æ÷¸· ¼¼Æ÷Á¾
    ¼¶À¯¾Æ¼¼Æ÷³ª ³­Æ÷¸· ¼¼Æ÷·Î ±¸¼ºµÈ´Ù. ±¸¼º ¼¼Æ÷°¡ ´ëºÎºÐ ³­Æ÷¸· ¼¼Æ÷ÀÎ ÀÌ Á¾¾çÀº È£¸£¸óÀ» »ý»êÇÒ ¼ö ÀÕ´Ù. ±×·¯³ª ¼ø¼öÇÑ ³­Æ÷¸· ¼¼Æ÷Á¾Àº µå¹°°í ´ëºÎºÐ Á¾¾çÀº ÁÖ·Î ¼¶À¯¸ð¼¼Æ÷·Î ±¸¼ºµÇ¾î ÀÖÀ¸¸ç È£¸£¸óÀ» »ý»êÇÏÁö ¾Ê´Â´Ù. 90%¿¡¼­ ÇÑÂÊ ³­¼Ò¿¡¼­¸¸ ¹ß»ýÇÑ´Ù. Á¾¾çÀº ȸ¹é»öÀÌ¸ç °íÇüÀÌ°í ±¸ÇüÀÌ¸ç ´Ü´ÜÇÏ´Ù. Á¶Á÷ÇÐÀûÀ¸·Î ¼¶À¯¸ð¼¼Æ÷¿Í ÄݶóÁ¨ °áü Á¶Á÷À¸·Î ±¸¼ºµÇ¾î ÀÖÀ¸¸ç ³­Æ÷¸· ¼¼Æ÷°¡ È¥ÀçÇÒ ¼ö ÀÖ´Ù. ȯÀÚ´Â °ñ¹ÝÅë°ú °ñ¹Ý Á¾±« µîÀÇ ºñƯÀÌÀû Áõ»óÀ» È£¼ÒÇϰųª º¹¼ö°¡ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ³­Æ÷¸· ¼¼Æ÷Á¾Àº ¾Ç¼ºÀÌ ¾ø´Ù.
  • fibrosing basal cell carcinoma
    ¼¶À¯¼º ±âÀú ¼¼Æ÷ ¾Ï
  • Finkeldey cell
    ÇÉÄ̵¥ÀÌ ¼¼Æ÷
    ¸¶Áø ȯÀÚÀÇ ÀÓÆÄ Á¶Á÷¿¡¼­ º¼ ¼ö ÀÖ´Â °Å´ë ¼¼Æ÷.
  • foam cell
    Æ÷¸» ¼¼Æ÷
  • follicular cell
    ¼ÒÆ÷ ¼¼Æ÷, ³­Æ÷ ¼¼Æ÷
  • foreign body giant cell
    À̹° °Å´ë ¼¼Æ÷, À̹° °Å¼¼Æ÷
  • hair cell
    ¸ð ¼¼Æ÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
myod protein A myogenic regulatory factor that controls myogenesis. Though it is not clear how its function differs from the other myogenic regulatory factors, myod appears to be related to fusion and terminal differentiation of the muscle cell.
(12 Dec 1998)
C protein <cell biology> Striated muscle thick filament associated proteins (140-150 kD) that show up in the C zone of the A band as 43nm transverse stripes. Structurally related to various other myosin binding proteins (twitchin, titin, myosin light chain kinase, skelemin, 86 kD protein, projectin, M protein).
(18 Nov 1997)
myotonin-protein kinase <enzyme> Has been sequenced
Registry number: EC 2.7.-
Synonym: mtpk, myotonin protein kinase
(26 Jun 1999)
C-reactive protein <protein> This blood test is used as an indicator of acute inflammation. C-reactive protein is a protein of the pentraxin family, produced by the liver during periods of inflammation and detectable in serum in various disease conditions particularly during the acute phase of immune response. Normally C-reactive protein should be negative in the bloodstream.
C-reactive protein is synthesised by hepatocytes and its production may be triggered by prostaglandin E1 or parogen. It consists of five polypeptide sub units forming a molecule of total molecular weight 105 kD. It binds to polysaccharides present in a wide range of bacterial, fungal and other cell walls or cell surfaces and to lecithin and to phosphoryl or choline containing molecules. It is related in structure to Serum Amyloid. And C polysaccharide.
Conditions which can cause a positive C-reactive protein include: rheumatoid arthritis, lupus, pneumococcal pneumonia, rheumatic fever, cancer, tuberculosis and myocardial infarction.
A positive C-reactive protein may also be seen in the later half of pregnancy and in some who are taking birth control pills.
See: acute phase proteins
(06 Oct 1997)
CRK4 protein kinase <enzyme> From mouse, has 85% amino acid identity with xenopus m015 protein kinase; genbank x74145
Registry number: EC 2.7.10.-
Synonym: crk4 pk
(26 Jun 1999)
H1-related protein-tyrosine phosphatase <enzyme> Has tyrosine and threonine/serine phosphatase activities
Registry number: EC 3.1.3.-
Synonym: vaccinia virus h1-related protein tyrosine phosphatase, vhr ptpase, vh-ptp13
(26 Jun 1999)
cro protein <protein> Protein synthesised by bacteriophage lambda in the lytic state. The cro protein blocks the synthesis of the lambda repressor (that is produced in the lysogenic stage and inhibits cro protein synthesis). Production of the cro protein in turn controls a set of genes associated with rapid virus multiplication.
(18 Nov 1997)
haemagglutinin-neuraminidase protein <protein> A protein found in the capsid of the Sendai virus which is exceptionally good at binding to the cytoplasmic membranes of many animal cells. The protein is therefore used to make fusogenic vesicles for the purpose of delivering therapeutic drugs or other chemicals directly into cells.
(09 Oct 1997)
crude protein Incomplete proteins which lack essential amino acids.
(09 Oct 1997)
crystalline protein <protein> The major protein found in the lens of the vertebrate eye, it can be dissolved in water easily.
(09 Oct 1997)
Csk-like protein-tyrosine kinase <enzyme> Phosphorylates c-terminal conserved tyr of src family members; from mouse brain; has 52% identity with mouse csk; mw 52 kD; genbank u05210
Registry number: EC 2.7.1.-
Synonym: ctk (kinase), ctk gene product, csk-type protein-tyrosine kinase, ntk (kinase), bhk (kinase)
(26 Jun 1999)
C-terminal leucine protein methyltransferase <enzyme> Reversibly modifies protein phosphatase 2a by methyl esterification at its c-terminal leucine residues
Registry number: EC 2.1.1.-
Synonym: tlp methyltransferase
(26 Jun 1999)
PP5 protein-serine-threonine phosphatase <enzyme> Has 4 tetratricopeptide repeat (tpr) motifs; similar to ppt1 protein; do not confuse with the placental protein pp5; amino acid sequence given in first source
Registry number: EC 3.1.3.-
Synonym: pp5 phosphatase, protein phosphatase 5
(26 Jun 1999)
pp65 protein <protein> A protein made by a cytomegalovirus which prevents the cell that the virus has infected from displaying fragments of viral proteins, called antigens, on the cells surface. In this way the cytomegalovirus is able to evade the bodys immune system, more or less permanently.
(09 Oct 1997)
P protein <protein> Protein found in large amounts in phloem seive tubes. Appears as thin strands when seen in the electron microscope.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
ÅëÇÕ°Ë»ö ¿Ï·á